Health & Life Co., Ltd. (1781) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Health & Life Co., Ltd. (1781:TWSE), powered by AI.

Current Price
$11.95
Sector
Healthcare
What is the Health & Life Co., Ltd. stock price forecast?

Health & Life Co., Ltd. is currently trading at $11.95. View real-time AI analysis on Alpha Lenz.

What is Health & Life Co., Ltd. insider trading activity?

View the latest insider trading data for Health & Life Co., Ltd. on Alpha Lenz.

What is Health & Life Co., Ltd.'s P/E ratio?

View Health & Life Co., Ltd.'s valuation metrics on Alpha Lenz.

Health & Life Co., Ltd.

TWSE · 1781
NT$11.95-0.05(-0.42%)
Ask about Health & Life Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Health & Life Co., Ltd.'s ROE is -17.3%. Explore profitability and growth together.

Ask for details

Company Overview

Health & Life Co., Ltd. is a medical technology manufacturer specializing in health technology, with a primary focus on products for cardiovascular disease management, in-vitro diagnostics, and respiratory care. Established in 1996 and headquartered in Taipei, Taiwan, the company is recognized for its research-driven approach and commitment to quality and continuous product innovation. Health & Life Co., Ltd. develops and distributes a wide array of medical devices, including digital blood pressure monitors, blood glucose meters, nebulizers, and electronic thermometers, which are distributed globally under both its own and OEM brands. The firm's expertise encompasses engineering, manufacturing, and international regulatory compliance, with multiple patents for advancements in blood pressure measurement and diagnostic technologies. Health & Life Co., Ltd. plays a vital role in the medical equipment supply chain, supporting healthcare providers and patients worldwide by improving access to essential monitoring and diagnostic tools, and is regarded as an important contributor to advancements in non-invasive and preventive health management solutions.

SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$398.05MRevenue
0.00Shares Out
0Employees

Margins

17.62%Gross
-11.73%EBITDA
-15.93%Operating
-16.92%Pre-Tax
-15.49%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-20.68%Rev 3Yr
-12.46%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-8.01%ROA
-17.28%ROE
-7.97%ROIC

Financial Health

NT$247.65MCash & Cash Equivalents
NT$154.91MNet Debt
125.58%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Health & Life Co., Ltd. (ticker: 1781) is a company listed on TWSE in the Healthcare sector (Medical Devices).

The current price is 11.95 with a P/E ratio of -x and P/B of -x.

ROE is -17.28% and operating margin is -15.93%. Annual revenue is $398M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Health & Life Co., Ltd. (1781) Stock Forecast 2026 $11.95 — Price, Financials & Analyst Targets | Alpha Lenz